Metrion Biosciences

OverviewSuggest Edit

Metrion Biosciences is a contract research organization specializing in ion channel screening and drug development. It also offers a range of in vitro screening services that include cardiac safety and neurotoxicology testing and phenotypic assays.
HQCambridge, GB

Latest Updates

Employees (est.) (Nov 2021)24(+5%)
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Metrion Biosciences

Keith McCullagh

Keith McCullagh

Non-Executive Chairman
Marc Rogers

Marc Rogers

Founding Director and Chief Scientific Officer
Barry Kenny

Barry Kenny

Non-Executive Director
Mark Keogh

Mark Keogh

Non-Executive Director
Show more

Metrion Biosciences Office Locations

Metrion Biosciences has an office in Cambridge
Cambridge, GB (HQ)
Riverside 3, Suite 1, Granta Park, Great Abington
Show all (1)

Metrion Biosciences Financials and Metrics

Summary Metrics

Founding Date


Metrion Biosciences total Funding

$4.9 m

Metrion Biosciences latest funding size

$3.81 m

Time since last funding

8 months ago

Metrion Biosciences investors

Metrion Biosciences's latest funding round in April 2021 was reported to be $3.8 m. In total, Metrion Biosciences has raised $4.9 m
Show all financial metrics

Metrion Biosciences Online and Social Media Presence

Embed Graph

Metrion Biosciences News and Updates

Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration with Metrion Biosciences

TOKYO and CAMBRIDGE, England, Feb. 1, 2021 /PRNewswire/ -- Sosei Group Corporation ("the Company"; TSE: 4565) announces it will apply its world-leading structure-based drug design (SBDD) expertise and platform to ion channels for the first time through a new strategic collaboration with...

Metrion Biosciences Blogs

Alex’s Story So Far…

Written by Dr Alex Howarth Metrion Scientist Dr Alexander Howarth summarises below his undergraduate and postgraduate studies and how he came to join Metrion Biosciences. “In 2015, I graduated from the University of Sheffield with a BSc in Biomedical Sciences. The degree was fascinating and provided…

Pete’s Path into Electrophysiology

Written by Dr Peter Matthews Metrion Scientist Dr Peter Matthews summarises below his path into electrophysiology and recounts his experiences during his undergratuate and postgraduate studies and beyond. “I first became interested in the physiology and pharmacology of ion channels during my undergr…

Metrion Biosciences appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development

Metrion Biosciences appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development Appointment supports international growth within ion channel contract research and drug discovery Cambridge, UK, 26 July 2021: Metrion Biosciences Limited (“Metrion”), the specialist ion chan…

Discovery of KNa1.1 channel inhibitors – an account of Metrion’s first webinar

Metrion’s first “Ion channel drug discovery” webinar Metrion Biosciences’ inaugural ion channel webinar took place at the end of June and featured a presentation by Dr Jon Lippiat, from the School of Biomedical Sciences at the University of Leeds. Jon presented an inspiring and thought-provoking tal…

The Ionic Inspiration of Venomtech – by Steve Trim

Our guest blog, written by longstanding Friend and Collaborator Steve Trim, CSO and Founder of Venomtech is presented below. An early career at Pfizer, Sandwich “Why spider man is joining forces with ion man” is a newspaper headline I’ll never forget, and one of the few puns about my work that I rea…

Metrion Biosciences Appoints Mark Keogh as Non-Executive Director

Metrion Biosciences appoints Mark Keogh as Non-Executive Director Appointment strengthens the financial and corporate experience of Metrion’s Board in support of the Company’s planned international growth Cambridge, UK, 19 April 2021: Metrion Biosciences Limited (“Metrion”), the specialist ion chann…
Show more

Metrion Biosciences Frequently Asked Questions

  • When was Metrion Biosciences founded?

    Metrion Biosciences was founded in 2015.

  • Who are Metrion Biosciences key executives?

    Metrion Biosciences's key executives are Keith McCullagh, Marc Rogers and Barry Kenny.

  • How many employees does Metrion Biosciences have?

    Metrion Biosciences has 24 employees.

  • Who are Metrion Biosciences competitors?

    Competitors of Metrion Biosciences include Parsolex, Selvita and Selcia.

  • Where is Metrion Biosciences headquarters?

    Metrion Biosciences headquarters is located at Riverside 3, Suite 1, Granta Park, Great Abington, Cambridge.

  • Where are Metrion Biosciences offices?

    Metrion Biosciences has an office in Cambridge.

  • How many offices does Metrion Biosciences have?

    Metrion Biosciences has 1 office.